Erectile Dysfunction


Read the guidelines for AAFP endorsements.

Find a patient education handout on this topic.

Endorsement of Guidelines for Testing and Treatment of Erectile Dysfunction

Recommendation 1: The American College of Physicians recommends that clinicians initiate therapy with a PDE-5 inhibitor in men who seek treatment for erectile dysfunction and who do not have
a contraindication to PDE-5 inhibitor use (Grade: strong recommendation; high-quality evidence).

Recommendation 2: The American College of Physicians recommends that clinicians base the choice of a specific PDE-5 inhibitor on the individual preferences of men with erectile dysfunction, including ease of use, cost of medication, and adverse effects profile (Grade: weak recommendation; low-quality evidence).

Recommendation 3:
The American College of Physicians does not recommend for or against routine use of hormonal blood tests or hormonal treatment in the management of patients with erectile dysfunction (Grade: insufficient evidence to determine net benefits and harms).

American College of Physicians (ACP): Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction(12 page PDF) -- (Endorsed August 17, 2011)